Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Hit 52-Week High

Shares in Bruker BioSciences briefly climbed to a 52-week high of $5.70 this week, before closing up 11.75 percent to $5.61 on Tuesday. The firm's shares rose this past week after announcing a biodefense contract for the United Arab Emirates. Molecular Devices also hovered near a 52-week high, closing up 8.89 percent for the tracking period ended Tuesday.

Harvard Bioscience led decliners for the week, closing the period down 7.39 percent.

Overall, the BCW Index closed up 1.89 percent, while the Nasdaq rose 1.77 percent, the Nasdaq Biotech Index gained .2 percent, and the Dow Jones Industrial Average rose .4 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Apr. 4, 2006)
Last Price
(Mar. 28, 2006)
% change
Agilent
A
38.05
36.27
4.91
Applied Biosystems
ABI
27.09
27.52
-1.56
Beckman
BEC
54.21
54.68
-0.86
Bio-Rad
BIO
62.74
58.51
7.23
Bruker
BRKR
5.61
5.02
11.75
Fisher Scientific
FSH
68.16
68.81
-0.94
GE
GE
34.7
33.6
3.27
Harvard Bio
HBIO
4.01
4.33
-7.39
Invitrogen
IVGN
68.24
70.72
-3.51
Molecular Devices
MDCC
34.29
31.49
8.89
PerkinElmer
PKI
23.4
23.15
1.08
Qiagen
QGEN
14.53
14.63
-0.68
Sigma
SIAL
66.6
64.32
3.54
Stratagene
STGN
10.72
10.29
4.18
Thermo
TMO
36.96
36.12
2.33
Waters
WAT
43.95
42.79
2.71
BCW Index Average
37.08
36.39
1.89
The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.